title: Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones.
abstract: Fabry_CEP is a user-friendly web-application designed to help clinicians Choose Eligible Patients for the therapy with pharmacological chaperones. It provides a database and a predictive tool to evaluate the responsiveness of lysosomal alpha-galactosidase mutants to a small molecule drug, namely 1-Deoxy-galactonojirimycin. The user can introduce any missense/nonsense mutation in the coding sequence, learn whether it is has been tested and gain access to appropriate reference literature. In the absence of experimental data structural, functional and evolutionary analysis provides a prediction and the probability that a given mutation is responsive to the drug.
authors.affiliation: Dipartimento di Biologia, Università Federico II, Napoli, Italy.
authors.forename: Marco
authors.initials: M
authors.lastname: Cammisa
authors.forename: Antonella
authors.initials: A
authors.lastname: Correra
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Andreotti
authors.forename: Maria Vittoria
authors.initials: MV
authors.lastname: Cubellis
mesh_terms: D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D062313:Databases, Pharmaceutical; D000795:Fabry Disease / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D020407:Internet; D018832:Molecular Chaperones / Q000627:therapeutic use*; D009154:Mutation; D016896:Treatment Outcome; D000519:alpha-Galactosidase / Q000235:genetics*
chemical_list: D018832:Molecular Chaperones; D017485:1-Deoxynojirimycin; C090092:migalastat; D000519:alpha-Galactosidase